Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Euroscreen: Home for orphan receptors

Euroscreen: Home for orphan receptors

One of the many bottlenecks downstream from the sequencing of the human genome is the characterization of the functions of novel genes and turning them into validated therapeutic targets. A particularly alluring area is orphan G protein-coupled receptors.

Finding the ligands for these orphan receptors is the focus of Euroscreen s.a., which was formed in 1994 based

Read the full 617 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE